CRISPR Therapeutics CFO Raju Prasad to step down
The company said Prasad is leaving to pursue external opportunities, and the announcement was made October 19, 2026.
GetSignal CRISPR Therapeutics AG CRSP
CRISPR Therapeutics said on October 19, 2026 that Chief Financial Officer Raju Prasad, Ph.D., is stepping down from the company to pursue external opportunities.
Key facts
- Officer
- Raju Prasad, Ph.D., Chief Financial Officer
- Reason
- To pursue external opportunities
- Announced
- October 19, 2026
Source: The company's release on GlobeNewswire, October 19, 2026.
Written by GetSignal with AI from the company's press release.
Not investment advice.
